Insulin for Diabetes-Related Cystic Fibrosis

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Diabetes-Related Cystic FibrosisInsulin - Drug
Eligibility
18 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether using a CGM to help calculate meal-time insulin doses leads to better blood sugar management for people with CF than the current standard method.

Eligible Conditions
  • Diabetes-Related Cystic Fibrosis

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 2 weeks

2 weeks
Hypoglycemia duration
Hypoglycemia number
Time in Target

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

1 Treatment Group

Fixed Dosing, Followed by Carbohydrate Counting
1 of 1

Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Insulin · No Placebo Group · Phase 4

Fixed Dosing, Followed by Carbohydrate CountingExperimental Group · 2 Interventions: Insulin, Continuous glucose monitor (CGM) · Intervention Types: Drug, Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Insulin human
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 weeks

Who is running the clinical trial?

Wake Forest University Health SciencesOTHER
1,127 Previous Clinical Trials
1,137,407 Total Patients Enrolled
Jagdeesh UllalLead Sponsor
Jagdeesh Ullal, MD3.86 ReviewsPrincipal Investigator - University of Pittsburgh Medical Center
University of Pittsburgh
5Patient Review
He was phenomenal. Not only did he listen to my issues, but he provided additional resources and called me back to review my lab results.

Eligibility Criteria

Age 18 - 80 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are over the age of 18 years.